BENITO
VELAYOS JIMENEZ
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
![Foto de BENITO](/img/nophoto.png)
![Foto de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (6)
2024
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2019
-
Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers
The American journal of gastroenterology, Vol. 114, Núm. 5, pp. 771-776
2015
-
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
Alimentary Pharmacology and Therapeutics, Vol. 41, Núm. 8, pp. 768-775
2012
-
Accuracy of urea breath test performed immediately after emergency endoscopy in peptic ulcer bleeding
Digestive Diseases and Sciences, Vol. 57, Núm. 7, pp. 1880-1886